Literature DB >> 27696484

Newborns still lack drug data to guide therapy.

Robert M Ward1, Catherine M Sherwin1.   

Abstract

Mesh：

Year:  2016        PMID： 27696484      PMCID： PMC5099549          DOI： 10.1111/bcp.13074

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  An update on the therapeutic orphan.

Authors:  J T Wilson
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

2.  Global Collaboration to Develop New and Existing Drugs for Neonates.

Authors:  Jonathan M Davis; Mark A Turner
Journal:  JAMA Pediatr       Date:  2015-10       Impact factor: 16.193

3.  Newborns, one of the last therapeutic orphans to be adopted.

Authors:  Justin L Stiers; Robert M Ward
Journal:  JAMA Pediatr       Date:  2014-02       Impact factor: 16.193

Review 4.  Ethics of drug studies in the newborn.

Authors:  Robert M Ward; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

5.  Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.

Authors:  Barbara Schmidt; Peter J Anderson; Lex W Doyle; Deborah Dewey; Ruth E Grunau; Elizabeth V Asztalos; Peter G Davis; Win Tin; Diane Moddemann; Alfonso Solimano; Arne Ohlsson; Keith J Barrington; Robin S Roberts
Journal:  JAMA       Date:  2012-01-18       Impact factor: 56.272

6.  Drug labeling and exposure in neonates.

Authors:  Matthew M Laughon; Debbie Avant; Nidhi Tripathi; Christoph P Hornik; Michael Cohen-Wolkowiez; Reese H Clark; P Brian Smith; William Rodriguez
Journal:  JAMA Pediatr       Date:  2014-02       Impact factor: 16.193

Review 7.  Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates.

Authors:  Kok Pim Kua; Shaun Wen Huey Lee
Journal:  Br J Clin Pharmacol       Date:  2016-09-30       Impact factor: 4.335

8.  Long-term effects of caffeine therapy for apnea of prematurity.

Authors:  Barbara Schmidt; Robin S Roberts; Peter Davis; Lex W Doyle; Keith J Barrington; Arne Ohlsson; Alfonso Solimano; Win Tin
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

9.  Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.

Authors:  Rosemary Roberts; William Rodriguez; Dianne Murphy; Terrie Crescenzi
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

10.  How do institutional review boards apply the federal risk and benefit standards for pediatric research?

Authors:  Seema Shah; Amy Whittle; Benjamin Wilfond; Gary Gensler; David Wendler
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272
View more
  6 in total

1.  The Need for Pediatric Drug Development.

Authors:  Robert M Ward; Daniel K Benjamin; Jonathan M Davis; Richard L Gorman; Ralph Kauffman; Gregory L Kearns; Mary Dianne Murphy; Catherine M T Sherwin
Journal:  J Pediatr       Date:  2017-09-21       Impact factor: 4.406

2.  The Utility of Pharmacometric Models in Clinical Pharmacology Research in Infants.

Authors:  Guohua An
Journal:  Curr Pharmacol Rep       Date:  2020-08-18

3.  Large differences in neonatal drug use between NICUs are common practice: time for consensus?

Authors:  Robert B Flint; Floor van Beek; Peter Andriessen; Luc J Zimmermann; Kian D Liem; Irwin K M Reiss; Ronald de Groot; Dick Tibboel; David M Burger; Sinno H P Simons
Journal:  Br J Clin Pharmacol       Date:  2018-04-17       Impact factor: 4.335

4.  The culture of research communication in neonatal intensive care units: key stakeholder perspectives.

Authors:  Jennifer Degl; Ronald Ariagno; Judy Aschner; Sandra Beauman; Wakako Eklund; Elissa Faro; Hiroko Iwami; Yamile Jackson; Carole Kenner; Ivone Kim; Agnes Klein; Mary Short; Keira Sorrells; Mark A Turner; Robert Ward; Scott Winiecki; Christina Bucci-Rechtweg
Journal:  J Perinatol       Date:  2021-10-18       Impact factor: 2.521

5.  Comparison of antibiotic dosing recommendations for neonatal sepsis from established reference sources.

Authors:  T B Y Liem; E M A Slob; J U M Termote; T F W Wolfs; A C G Egberts; C M A Rademaker
Journal:  Int J Clin Pharm       Date:  2018-01-16

Review 6.  Dose-Related Adverse Drug Events in Neonates: Recognition and Assessment.

Authors:  Karel Allegaert; John van den Anker
Journal:  J Clin Pharmacol       Date:  2021-06       Impact factor: 3.126
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.